Seloken.com
Seloken is ranked > 3,000,000 in the United Kingdom. 'Late-breaking clinical trials: Treating to New Targets (TNT) study.'
--Rank in United Kingdom
--Worldwide Rank
| Monthly pages viewed | < 300 | |
| Monthly visits | < 300 | |
| Value per visitor | -- | |
| Estimated worth | £332.85 | |
| External links | 2 | |
| Number of pages | 225 |
Last Updated: 05/04/2018 . Estimated data, read disclaimer.
Content
www.Seloken.com
- Popular pages
- seloken.com Late-breaking clinical trials: Treating to New Targets (TNT) study
- seloken.com BNP evaluation facilitates HF management in several settings
- seloken.com Pros and cons of aggressive lipid-lowering therapy
- seloken.com This website is now closed
- seloken.com Controversy over left ventricular dysfunction treatment
- Links out
- bmj.com bmj.com
- astrazeneca-us.com AstraZeneca Pharmaceuticals - U.S. Home Page
- astrazeneca.co.uk Welcome to AstraZeneca.co.uk
- astrazeneca.com AstraZeneca - a global research-based biopharmaceutical company
| Server Location | |
| Mci Uunet Sweden Solna Sweden 59.37, 18.02 | |
The server is hosted by Mci Uunet Sweden Solna. It has 3 DNS records, nsgbr.comlaude.co.uk, ns1.astrazeneca.com, and ns2.astrazeneca.com. Seloken.com's IP address is 212.209.25.26.
IP: 212.209.25.26